Carestream to highlight Stage 1 and Stage 2 Meaningful Use certification of the Vue RIS, and updates to the Vue PACS platform at RSNA 2014.
Carestream at RSNA 2014 will highlight new certification for its RIS and updates to its PACS products.
Carestream announces that its Vue RIS is one of the first to achieve certification for Stage 1 and Stage 2 Meaningful Use capabilities. The certification allows Vue RIS to exchange patient medical records and clinical documents with other certified EHR providers, Carestream said. Stage 2 capabilities include family health history, health information portability and sharing, online patient access to information and communication, and changes to comply with the way information is tracked so it can be more effectively shared and improve overall patient outcomes, Carestream said.
The latest version of Vue RIS will be available in the U.S. in December 2014.
[[{"type":"media","view_mode":"media_crop","fid":"29540","attributes":{"alt":"Carestream Vue RIS","class":"media-image","id":"media_crop_6691737949041","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"3056","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 373px; width: 440px; border-width: 0px; border-style: solid; margin: 1px;","title":"Carestream Vue RIS","typeof":"foaf:Image"}}]]
Carestream’s Vue PACS platform offers new capabilities, including 64-bit architecture that provides enhanced processing power for radiologists to manage large imaging data sets and use complex analysis and automatic registration features to read 3D imaging studies, Carestream said.
The Vue PACS will offer a new voice recognition tool that enables radiologists to insert hyperlinks that can contain key images and quantitative comparisions, such as vessel analysis and measurements, into the final report, Carestream said.
Carestream said the zero-footprint Vue Motion viewer can be embedded into the EMR to allow access of 3D/MPR images, multimedia reports, and non-DICOM videos and photos to remote physicians from their mobile devices or workstations.
[[{"type":"media","view_mode":"media_crop","fid":"29541","attributes":{"alt":"Carestream Vue PACS","class":"media-image","id":"media_crop_1965332919944","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"3057","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 293px; width: 440px; border-width: 0px; border-style: solid; margin: 1px;","title":"Carestream Vue PACS","typeof":"foaf:Image"}}]]
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
MRI Long Covid Study Reveals Link Between Lower Pulmonary Gas Exchange and Cognitive Dysfunction
November 26th 2024For patients with Long Covid, lower pulmonary gas exchange may be associated with lower gray and white matter volume, according to new MRI research to be presented at the Radiological Society of North America (RSNA) conference.
New DEXA Scan Study Links Thyroid Medication Levothyroxine to Higher Bone Loss Risk in Seniors
November 25th 2024Use of the medication levothyroxine, commonly prescribed for hypothyroidism, was associated with greater long-term loss of total body bone mass in seniors, according to new DEXA research to be presented at the Radiological Society of North America (RSNA) conference.